Taken collectively, these findings indicate that CAMTA1 overexpression can render colorectal cancer cells more sensitive to oxaliplatin, and thus, this approach may hold clinical promise in the future, although prolonged gene overexpression in rapidly growing tumors is presently a challenge. Here, CAMTA1 is linked to colorectal cancer.